Hippocampus-dependent memory involves the activity of sharp wave ripples (SWRs), which are thought to participate in the process of memory consolidation. The hippocampus contains high levels of endogenous opioids and of m-opioid receptors (MORs). Here, we have assessed the role of MOR agonists in the modulation of SWRs.
Introduction
Endogenous and clinically administered opioids act on many receptors (Waldhoer et al., 2004) and are involved in a wide variety of functions (Drolet et al., 2001 ) including hippocampus-dependent learning and memory (Wise, 1989; Meilandt et al., 2004; Bodnar, 2010; Kesner and Warthen, 2010; Dacher and Nugent, 2011) . Nevertheless, the mechanisms by which opioids affect hippocampus-dependent memory appear to be highly complex and poorly understood.
The critical involvement of the hippocampus in learning and memory (Eichenbaum, 2004; Squire et al., 2004 ) is underpinned by a number of different types of neuronal activity supporting distinct processes (Battaglia et al., 2011) . For example, it is assumed that the encoding of new information that occurs during active behaviour is associated with q oscillation (Hasselmo, 2005) whereas memory consolidation takes place during inactivity (Alvarez and Squire, 1994; McGaugh, 2000) . It is generally thought that memory consolidation entails the generation of irregular activity of sharp wave ripples (SWRs) (O'Neill et al., 2010) , which is an endogenous hippocampal activity that occurs during awake quietness and slow wave sleep. This activity was first recorded in rodents (O'Keefe and Nadel, 1978; Buzsaki, 1986 ) and more recently in primates and humans (Bragin et al., 1999; Skaggs et al., 2007) . SWR activity is thought to represent a 'carrier' of information from the hippocampus to the neocortex (Wierzynski et al., 2009) in a process that is repeated off-line; this leads to long-term establishment of the memory in the neocortex, that is, consolidation (McGaugh, 2000) . Accordingly, changes in the activity of SWRs have recently been correlated with performance in hippocampus-dependent learning and memory (Girardeau et al., 2009; Ramadan et al., 2009; Singer and Frank, 2009; Ego-Stengel and Wilson, 2010) . SWRs are a complex field activity generated by the CA3 and CA1 hippocampal circuits and consist of a slow potential that lasts for 50-100 ms (sharp wave), which is generated by synaptic activity on pyramidal cells (Ylinen et al., 1995; Papatheodoropoulos and Kostopoulos, 2002; Maier et al., 2003) and a high-frequency (100-200 Hz) network oscillation (ripples) that occurs during the sharp wave and is the result of a rather complicated and spatio-temporally coordinated interaction between principal cells and circuits of specific classes of GABAergic interneurons (Chrobak and Buzsaki, 1994; Klausberger et al., 2004) . Specific classes of GABAergic interneurons that innervate other types of interneurons are among the main sources of endogenous opioids in the hippocampus (Gall et al., 1981; Chavkin et al., 1985; BlascoIbanez et al., 1998) . The hippocampus contains a relatively high level of opioid receptors (Zastawny et al., 1994) , and the most abundant opioid receptors in the rat hippocampus belong to the class of m-opioid receptors (MORs) (Mansour et al., 1987 ; receptor nomenclature follows Alexander et al., 2011) . MORs are found in the dentate gyrus and CA3 and CA1 fields (Schnell and Wessendorf, 2008) , and they are strongly expressed by and strategically located on those GABAergic interneurons that target the somatic domain of principal cells (Drake and Milner, 2002) . In addition, within the perisomatically projecting GABAergic cells, MORs are selectively located on parvalbumin (PV)-expressing cells (Drake and Milner, 2002) . Interestingly, PV cells in CA1 field belong to those GABAergic neurons that intensively increase their firing rate during SWRs (Klausberger et al., 2004) , and they are the preferred targets of the recently discovered enkephalin-expressing GABAergic cells that are silent during SWRs but strongly activated after episodes of SWRs (Fuentealba et al., 2008b) .
In order to better understand how the various neurotransmission and neuromodulation systems are involved in learning and memory, it is necessary to understand their interactions with the functioning of local brain circuits. The results from earlier studies suggest that opioid agonists acting at MORs might significantly affect information processing in the hippocampus. For example, MORs modulate temporal integration of synaptic activity in the hippocampus (McQuiston, 2011 ) and disrupt g (Whittington et al., 1998) and b oscillation (Faulkner et al., 1999) , yet the role of MOR in the modulation of the complex activity of SWRs remains unknown. In the present study using a recently developed in vitro model of SWRs in slices from the rat ventral hippocampus (Papatheodoropoulos and Kostopoulos, 2002) , we aimed to determine the modulatory effects of opioid agonists that act primarily at MORs on the activity of SWRs. Using morphine, DAMGO and fentanyl over a wide range of concentrations that included clinically relevant concentrations and concentrations that were similar to extracellular concentrations of endogenous opioids, we found that all three opioid agonists significantly modulated SWRs. However, their effects were not identical but differed between the various characteristics of SWRs. The present findings demonstrate that MOR agonists significantly modulate SWRs and also suggest that this action may be mediated by modifications of the balance between excitation and inhibition of the local neuronal circuit.
Methods
All animal care and experimental procedures complied with the European Communities Council Directive Guidelines (86/609/EEC) for the care and use of laboratory animals and were approved by the local Ethical Committee of the University of Patras. Male Wistar rats (200-400 g; Hellenic Pasteur Institute, Athens, Greece) were housed under controlled conditions of temperature (20-22°C), 12/12 h light-dark cycle, and free access to food and water. All measures were taken to minimize animal suffering and to reduce the number of the animals used. Studies involving animals are reported in accordance with the ARRIVE guidelines for reporting experiments involving animals McGrath et al., 2010) . In the present study 71 Wistar rats were used. of 500-550 mm thick were prepared from the ventral hippocampus, extending between 1 and 4 mm from the end of the structure using a McIlwain tissue chopper (Mickle Laboratory Engineering Co. Ltd, Gomshall, Surrey, UK). The slices were immediately transferred to an interface type recording chamber where they were maintained at a constant temperature of 31 Ϯ 0.5°C. Slices were continuously supplied with a humidified mixed gas containing 95% O2 and 5% CO2 and they were perfused with standard artificial cerebrospinal fluid containing (in mM): 124 NaCl, 4 KCl, 2 MgSO4, 2 CaCl2, 1.25 NaH2PO4, 26 NaHCO3, and 10 glucose, pH 7.4, equilibrated with 95% O2 and 5% CO2 gas mixture.
Recordings and data processing
Recordings started approximately 3 h after the slices were placed in the recording chamber to allow them to recover and organize spontaneous activity. Recordings of spontaneous and evoked extracellular potentials were made from the CA1 stratum pyramidale using carbon fibre electrodes (diameter 7 mm; Kation Scientific, Minneapolis, MN, USA). Evoked synaptic responses consisting of field EPSPs and population spikes (PSs) were recorded by delivering electrical pulses (intensity 0.1-0.6 mA, duration 0.1 ms) at the Schaffer collaterals using a bipolar platinum/iridium wire electrode (wire diameter of 25 mm; World Precision Instruments, Sarasota, FL, USA). PS with amplitude of about 2 mV was evoked every 30 s and continuously monitored in order to determine the stability of the response. Only slices with a stable response for at least 10 min were selected for further experimentation. Signals were recorded with a Neurolog amplifier (Digitimer Limited, Welwyn Garden City, Hertforshire, UK), band-pass filtered at 0.5 Hz-2 kHz, digitized at 5 kHz, and stored in a computer disc using the CED 1401-plus interface and the Spike5 and Signal software (Cambridge Electronic Design, Cambridge, UK).
As described in Results section, episodes of spontaneous network potentials identified as SWR activity consisted of either isolated single events or sequences of multiple consecutive events termed clusters (see Figure 1A) . We call the first event in a sequence the primary event, while the subsequent events are called secondary events. Events were further analysed into slow and fast components, the slow sharp wave and the high-frequency ripple oscillation (which, in rats, peaks at 110-200 Hz). The following parameters were quantified: the inter-episode interval (IEpI) determined as the time interval between episodes, that is, the interval between the last event of an episode and the first event of the following episode; the inter-event interval (IEI) determined as the time interval between successive individual SPWs regardless of whether they appeared as isolated events or clusters; the intra-cluster interval (ICI, the mean time interval between consecutive events inside a cluster); the probability of occurrence of clusters of SWRs (probability of clusters); the number of events per minute; and the number of episodes per minute. Additionally, the amplitude, the duration at half amplitude and the maximum duration of the primary event were also measured. IEI, IEpI, ICI, amplitude and duration were measured after down sampling (at 1-2 kHz) and then low-pass filtering (at 30 Hz) original data. Individual sharp waves were detected by setting a threshold at a level where all putative events were marked as verified by visual inspection. Measurements of the above parameters were made during the last 2 min before applying the drug and during the last 2 min of drug application. High-frequency ripple oscillation was revealed by applying fast Fourier transform or filtering original records at 90-300 Hz. We used power spectra to measure the power of the peak of the ripple oscillation. In filtered recordings, ripples were detected by setting a threshold at four times the SD of event-free baseline noise; we measured (i) the number of troughs of a ripple event; (ii) the duration of the ripple event; (iii) the amplitude of the ripple event; and (iv) the mean intra-ripple frequency during each event. In episodes consisting of multiple events (i.e. clusters), measurements of ripple parameters were obtained from the primary event only. For accuracy reasons, all measurements were made manually, with the exception of ripple power that was measured using plots of fast Fourier transforms. In a given slice, the values obtained from the measurement of all sharp waves contained in the 2 min periods of control/drug conditions were averaged and the resulting mean value was the representative value from this particular slice. Manual measures of ripple characteristics from each slice were made from an epoch of 30 consecutive events inside the 2 min periods. Mean values of each ripple parameter were calculated by averaging the values of all 30 ripple episodes in a particular slice.
In order to examine the effects of opioid agonists on neuronal excitability and on GABA A receptor-mediated synaptic inhibition, we constructed input/output curves of the stimulation strength and the amplitude of PS, as well as of EPSP and PS before and during drug application. Neuronal excitability was quantified by measuring the strength of the stimulation required to produce half-maximal PS (I-50), the postsynaptic excitation required to produce half-maximal PS (EPSP50), and the ratio between PS and the corresponding EPSP50 (PS/EPSP). We quantified changes in excitability by measuring the changes of I-50, EPSP50 and PS/EPSP. PS was quantified from its amplitude, measured as the length of the projection of the negative peak on the line connecting the two positive peaks of the PS waveform. EPSP was quantified from the maximal slope of its rising phase.
Synaptic GABAA receptor-mediated recurrent inhibition was evoked using a protocol of paired-pulse stimulation consisting of two consecutive stimuli of identical intensity delivered at Shaffer collaterals with an inter-pulse interval of 10 ms. The strength of so-produced paired-pulse inhibition (PPI) was quantified using the ratio response evoked by the second (test) stimulus (PS2)/response evoked by the first (conditioning) stimulus (PS1). Based on the constructed input/ output curves and previous observations (Petrides et al., 2007) , the strength of PPI and its changes were measured at two specific points of the input/output curves. More specifically, the stimulation strengths causing 50% of the maximum PS were chosen to calculate the PS2/PS1 ratio. The effect of opioids on PPI was quantified from the change produced in the I50 (shift of I-50) as well as the change of the PS2/PS1 ratio.
Data analysis
Values are expressed as mean Ϯ SEM, and 'n' indicates the number of slices included in the analysis. In several instances, the number of animals is also given. For statistical comparisons (using paired and independent t-tests) of the drug effects on SWRs, measurements were made immediately before drug application and during the last 2-5 min of drug application.
The EC50 were calculated from log concentration-response curves after sigmoidal or non-linear (dose-response) fitting to experimental data. In case of lack of fit with the previous methods, polynomial fit was applied. For data analysis and preparation of figures we used the software SPSS 14 (SPSS Inc., Chicago, IL, USA) and Origin 7.5 (OriginLab Corporation, Northampton, MA, USA).
Materials
We used three opioid receptor agonists -morphine, the synthetic analogue of endogenous enkephalin [D-Ala 2 ,N-MePhe 4 ,Gly-ol 5 ]enkephalin (DAMGO), and fentanyl. All three agonists exhibit selectivity for MORs (Waldhoer et al., 2004; Crooks et al., 2006) . We also used the opioid receptor antagonist naloxone and the highly selective MOR antagonist, D-Phe-Cys-Tyr-D-Trp-Orn-Thr-Pen-Thr-NH2 (CTOP). Morphine, fentanyl and naloxone were obtained from SigmaAldrich, Taufkirchen, Germany. DAMGO and CTOP were purchased from Tocris Cookson Ltd, Bristol, UK. All drugs were first prepared as stock solutions and then were dissolved in the artificial cerebrospinal fluid and bath applied. Drug effects on the parameters of the spontaneous and evoked activity were measured 30 min after adding them to the perfusion medium. However, when low drug concentrations were used, measurements were also obtained at 60 min of application.
Results
Recordings of field potentials were made from the CA1 pyramidal cell layer of transverse ventral hippocampal slices maintained in standard conditions. Spontaneous activity was recorded from the majority of hippocampal slices (>80%) approximately 3 h after placing in the recording chamber. As shown in Figure 1A ,B, spontaneous activity consisted of relatively slow deflections with a main positive phase associated
Figure 1
The characteristics of SWR activity. (A) In the left panel recording from the CA1 pyramidal layer is shown with SWR complexes (upper trace) and the corresponding band-pass (90-300 Hz) filtered waveform revealing the ripple oscillation (lower trace). In this example are shown four episodes of activity, each of them consisting of a sequence of SWR events. The framed event is shown at fast sweep speed in the right upper panel. The power spectra in the bottom of the right panel illustrate the three peaks around 2, 10 and 160 Hz produced by the occurrence of SWR episodes (everỹ 500 ms), the occurrence of SWR events in sequences (every~100 ms), and the ripple oscillation. (B) Distribution histograms of the amplitude of sharp waves, the inter-event interval, the intra-cluster interval, and the frequency of ripple oscillation; 'n' indicates the number of slices used.
with multiunit activity. The amplitude of slow potentials ranged from 20 mV to 1 mV among slices. Band-pass filtering of original waveforms at 90-300 Hz disclosed a transient oscillation associated with the slow potentials. The mean frequency of this oscillation was~160 Hz forming a characteristic peak in power spectra made from the original records ( Figure 1A , right panel). The slow potentials in combination with the fast oscillation formed a complex activity that corresponds to SWRs recorded from the intact hippocampus (O'Keefe and Nadel, 1978) . Episodes of the compound activity of SWRs consisted of either single events or multiple events characteristically clustered in sequences of two to five events ( Figure 1A ). The generation of these sequences represents a regular mode of SWR occurrence in the intact hippocampus and the consecutive events within the sequences occurred at the particularly consistent interval of 107 Ϯ 2.1 ms (range 62-162 ms, n = 66 slices) ( Figure 1B ). In the present study, SWRs were recorded from more than 200 slices and drug effects were examined in 165 slices obtained from 71 animals. Figure 1B shows the distribution histograms for the amplitude of sharp waves, the IEI, the ICI as well as the ripple frequency. Primary sharp waves had mean amplitude of 232 Ϯ 17 mV (range 100-1000 mV, n = 133), duration of 51 Ϯ 1.7 ms (range 26-115 ms, n = 127) and episodes that occurred every 532 Ϯ 18 ms (range of IEpI 206-922 ms, n = 72). The sharp waveassociated ripple oscillation displayed a frequency of 163 Ϯ 1.6 Hz (range 121-195 Hz, n = 101). Furthermore, ripple events had an amplitude of 111 Ϯ 8.4 mV (range 26-254, n = 45) and duration of 35 Ϯ 1.7 ms (range 17.5-68.7, n = 45), and they consisted of 6.4 Ϯ 0.3 ripple cycles (range 3.5-12, n = 45). We observed that episodes of clustered SWR events (i.e. sequences) occurred in about 70% of the slices. Single events and sequences occurred with similar (~0.5) probability in the population of slices that displayed both types of episodes.
In order to examine whether tonic activity of MORs is implicated in the generation of SWRs, we perfused slices displaying ongoing SWRs with the wide-spectrum opioid antagonist naloxone or the selective MOR antagonist CTOP. None of the two drugs produced consistent effects on any of the parameters of SWRs. We then studied the effects of the three MOR agonists, morphine, DAMGO and fentanyl, used in a wide range of concentrations (1 nM-10 mM ), which includes concentrations similar to brain extracellular levels of endogenous opioids and clinically relevant concentrations of exogenous opioid agonists. Thus morphine, fentanyl and DAMGO were applied at concentrations (10 -9 to 10 -5 M) that included the nanomole regime covering the range of clinically relevant brain concentrations (Bouw et al., 2001) , the opioid concentrations found in the cerebrospinal fluid (Bernards et al., 2003) or the plasma/serum (Veselis et al., 1994; Klepstad et al., 2003; Gunnar et al., 2004; Solassol et al., 2005) as well as the extracellular levels of endogenous brain opioids (~1 to 10 nM) (Lam et al., 2008) .
In general, all three drugs displayed pronounced effects on SWRs. Most of the drug actions were concentrationdependent and qualitatively similar although they differed in magnitude. More specifically, all drugs significantly increased the amplitude of the primary sharp waves, the incidence of occurrence of sequences of SWRs, and the interval between episodes of SWRs (IEpI). It is of note that these effects were significant even at very low concentrations of 1-10 nM (Figures 2A, 3A & 4A) . As shown in Figures 2B, 3B and 4B, all MOR agonists increased the amplitude of sharp waves by 15-60%, and the interval between episodes (IEpI) by 6-280% in a concentration-dependent manner. The apparent consequence of the increased IEpI was the reduction in the rate of occurrence of episodes by 10-70%. Another effect of MOR agonists was the increase in the probability of occurrence of SWR sequences. The greatest effect was observed with a high concentration of DAMGO (1 mM) which elicited a 660% increase in this parameter. Because of the increased probability of occurrence of sequences, the total number of events was not changed at low concentrations of MOR agonists. However, when high concentrations were used, the reduction of the rate of episodes was high enough to surpass the increase in events due to an increase in clusters; this resulted in a significant reduction of the total number of events by 24-65%. In order to compare the potencies of the three drugs, we calculated the values of the EC 50 (in nM) for a given effect using concentration-response curves. As shown in Table 1 , the lowest EC50 values for all effects on sharp waves were observed with fentanyl, while morphine displayed the highest. DAMGO displayed rather intermediate EC50 values. We also estimated the relative potencies by pooling the EC50 values for all parameters together and calculating the mean EC50 value for the effect of each drug on sharp waves. The series of increasing potency was again morphine (269 Ϯ 59), DAMGO (182 Ϯ 66) and fentanyl (33.8 Ϯ 5.3).
Based on our observation that the effects of the drugs at high concentrations (>100 nM) reached a plateau after 15-25 min application (see e.g. Figures 3A-c and 4A-d) , we decided to make our measurements at 30 min. However, taking into account that equilibration between drug concentrations in the perfusion medium and the tissue might take , 10 -8 , 10 -7 , 10 -6 and 10 -5 M was respectively 10/4, 7/4, 7/4, 6/3, 8/4 for the amplitude, the IEpI, and the IEI, and 7/4, 6/4, 6/4, 4/3, 7/4 for the probability of clusters, the episodes per minute and the events per minute. *P < 0.05. Open circles at 5 and 10 nM represent measurements at 60 min of drug application and for these data, **P < 0.05. , 10 -8 , 10 -7 , 5 ¥ 10 -7 and 10 -6 M is respectively 12/5, 9/3, 8/3, 8/4, 9/8 for the amplitude, the IEpI, and the IEI, and 4/3, 3/3, 3/3, 4/3, 7/4 for the probability of clusters, the episodes per minute and the events per minute. *P < 0.05. Open circles at 5 and 10 nM represent measurements at 60 min of drug application and for these data, **P < 0.05.
Figure 4
The effects of fentanyl on sharp waves. (A) Examples of recordings (a, c) and scatter plot of instantaneous amplitude (b) and interval (d) are shown. In the experiment shown in 'd', note that naloxone fully reversed the effect of high concentration of fentanyl. (B) Concentration-response plots of the effects of fentanyl on the characteristics of sharp waves. The number of slices/animals used at the concentrations of 10 -9 , 10 -8 , 10 -7 , 5 ¥ 10 -7 and 10 -6 M was respectively 10/4, 12/6, 12/7, 6/3, 6/3 for the amplitude, the IEpI, and the IEI, and 4/3, 11/6, 9/5, 4/3, 7/4 for the probability of clusters, the episodes per minute and the events per minute. *P < 0.05. Open circles at 5 and 10 nM represent measurements at 60 min of drug application and for these data, **P < 0.05. longer at low than high concentrations, we examined the effects of the two lower concentrations (Յ10 nM) of all three MOR agonists at both 30 and 60 min after application. The rationale behind this was that if the action of a given MOR agonist used at a low concentration continued to increase beyond 30 min, it would be difficult to reach a safe conclusion about the action of low opioid concentrations. After we applied drugs for 30 min of additional time, we observed either no change or a small but not significant further effect of the drug. The effects of MOR agonists reversed upon application of naloxone (20 mM) or CTOP (3-5 mM) or by washing out the agonist (see examples in Figures 2A-d, 3A-b,d and 4A-b,c,d). MOR agonists did not produce any consistent effect on the interval between consecutive events in the sequences (ICI) or the half-maximal and the maximal duration of the primary sharp waves.
Although the effects of the three MOR agonists on sharp waves were qualitatively similar, their effects on the ripple oscillation differed (Figures 5 & 6) . All three drugs significantly suppressed ripples at moderate-to-high concentrations (Ն100 nM), with the effects being quantitatively similar between the three drugs. However, at lower concentrations (Յ10 nM) morphine, but not the other agonists, enhanced the ripple oscillation ( Figure 5 ). This enhancing effect was observed in all parameters of the oscillation and it was maximal at the lowest concentration of 5 nM, at which the observed increase in the amplitude, the number of ripples, the duration of ripple events, and the ripple power were 29%, 14%, 13% and 52% respectively. None of the MOR agonists significantly affected the frequency of the oscillation.
Effects of m-opioids on network excitability and recurrent inhibition
It is thought that the action of opioids in the hippocampus is produced mainly by a disinhibitory effect on the principal cells that results in an enhanced neuronal excitability of the network (Zieglgansberger et al., 1979; Nicoll et al., 1980; Masukawa and Prince, 1982; Swearengen and Chavkin, 1987) . We thus examined the effects of morphine (5 nM, 10 mM) and DAMGO (10 nM, 1 mM) on the neuronal network
Figure 5
Morphine enhanced ripple oscillation at low concentrations. Examples (A) and collective results (B) of the effects of morphine on the ripple oscillation. In each plot in (A), the power spectrum and the ripple oscillation are shown. The corresponding sharp waves are also indicated on the top of each plot. The number of slices/animals used at the concentrations of 5 nM, 10 nM, 0.1 mM and 1 mM was 16/8, 6/4, 13/7 and 13/7 respectively. *P < 0.05.
Figure 6
The effects of DAMGO (A) and fentanyl (B) on the ripple oscillation. Examples (power spectra and traces of sharp wave and ripples) and collective results for the power of the oscillation are shown. The number of slices/animals used at the concentrations of 10 -9 , 10 -8 , 10 -7 , 5 ¥ 10 -7 and 10 -6 M was 9/4, 3/2, 8/3, 8/4, 6/6 for DAMGO and 4/2, 11/6, 12/7, 4/2, 3/2 for fentanyl respectively. *P < 0.05. excitability and paired-pulse recurrent inhibition in 41 slices obtained from 27 animals. In general, both drugs affected network excitability and inhibition, yet some differences in their action were revealed. Figures 7 and 8 show examples of the effects of morphine and DAMGO respectively. Summary results are shown in Figure 9 . As shown by the excitability curves for morphine ( Figure 7A-a, B-a) and DAMGO ( Figure 8A-a, B-a) applied at relatively low concentrations (5-100 nM), neither of the two drugs significantly altered network excitability (see also Figure 9 ). However, at higher concentrations both morphine (1 and 10 mM, Figure 7C -a, D-b) and DAMGO (10 mM, Figure 8C -a) enhanced network excitability as shown by the leftward shift in the input/ output curves, the corresponding decrease in I50 and EPSP50, and the increase in PS/EPSP ratio (Figure 9 ). The opioidinduced shift to the left of the stimulus-to-PS and EPSP-to-PS curves is consistent with previous reports (Dingledine, 1981; Watson and Lanthorn, 1993) . Additionally, DAMGO was more potent than morphine in increasing network excitability, as shown by the lower mean EC50 value (i.e. from all three excitability indexes) of DAMGO (209) compared with morphine (517). Neither of the two drugs produced a consistent effect on the amplitude of maximal PS and maximal EPSP.
Striking results were obtained from the drug effects on inhibition. Their effects on PPI were measured using the decrease in the rightward displacement of the input/output curve of the second PS (PS2) in relation to the first PS (PS1) evoked by the paired-pulse stimulation. This effect was reflected in the lower shift of I50 and in the higher PS2/PS1 ratio. Although both drugs reduced PPI they displayed different profiles of action. As shown in Figures 7 and 9 , morphine reduced PPI only at 10 mM, whereas DAMGO reduced PPI at a much lower concentration (100 nM) ( Figures 8B and 9 ) and yielded a lower EC50 value for inhibition (60.4), compared with that for morphine (2033) (see Table 1 ). Thus, DAMGO was more potent than morphine in reducing inhibition. Furthermore, the mean EC50 value of DAMGO for inhibition was more than threefold lower than that for excitability (60.4 vs. 209), whereas morphine was less potent in reducing inhibition than in increasing excitability (mean EC50 values, 2033 and 517 respectively).
In addition to the changes in the excitability indexes derived from the input/output curve, both morphine and DAMGO at relatively high concentrations induced secondary PSs following a primary PS ( Figure 7C , D-d and Figure 8C ). This is in line with previous observations that opioid agonists induce secondary PSs in hippocampal slices (Dingledine, 1981; Swearengen and Chavkin, 1987; Watson and Lanthorn, 1993) . DAMGO was more effective than morphine in generating secondary spikes as its maximal effect was more than threefold greater than that of morphine ( Figure 9) ; this effect was produced at a lower concentration (1 mM vs. 10 mM). In addition to the above, DAMGO began inducing secondary spikes at a lower concentration than morphine (100 nM vs. 1 mM). This difference in potency was also expressed in the considerably lower EC 50 value for DAMGO (372.5) when compared with morphine (1578). In keeping with previous reports (Dingledine, 1981) , we found that the secondary spikes were completely blocked by naloxone ( Figures 7D-e  and 8C-b) . We also found that the secondary spikes induced by the MOR agonists were partly blocked by an antagonist of NMDA receptor CPP ( Figure 8C-c) , as previously reported (Swearengen and Chavkin, 1987) . The remaining component of secondary spikes that was not blocked by CPP was abolished by naloxone ( Figure 8C-d) . It has been previously shown that morphine reduces the post-spike afterhyperpolarization (Faulkner et al., 1999) . This reduction may lead to increased excitability in pyramidal cells and the appearance of multiple spikes (Azouz et al., 1996) . Consequently, the greater ability of DAMGO to induce secondary spikes may reflect a greater effect of this drug in enhancing NMDA receptor activity and/or reducing post-spike afterhyperpolarization when compared with morphine.
The difference in the effects of morphine and DAMGO on excitability and inhibition suggests that their mechanisms of action on the local neuronal circuit are not identical. Morphine and DAMGO have high affinity for MORs but they also bind to d, and k opioid receptors (Mansour et al., 1987; Waldhoer et al., 2004; Crooks et al., 2006) . M, d and k opioid receptors can be found in the CA1 field of the ventral hippocampus (Mansour et al., 1987) , the part of the hippocampus that has been used in the current study. Because these ᭤
Figure 7
Low concentrations of morphine enhance network excitability more than they affect recurrent inhibition (A) Examples of excitability curves obtained from one slice illustrating the effects of 5 nM morphine on the network excitability (a) and PPI (b) are shown. Input/output curves were made by plotting the PS amplitude against the stimulus strength before and during the application of the drug. Note that in (a), input/output curves were made for the first PS produced with the paired-pulse stimulation protocol, while in (b) curves were constructed for both the first and the second PS (PS1, black symbol and PS2, red symbol respectively) evoked by the pair of stimuli in order to illustrate the suppressive effect of the first stimulus to the second response attributed to the recurrent activation of GABAergic inhibition. At 5 nM, morphine did not produce any significant change in either the excitability curve (a) or the suppressing effect of the inhibition on the PS2. (B) Examples of excitability curve (a) with recordings of paired-pulse evoked potentials and concomitant spontaneous SWRs (upper and bottom traces respectively) obtained from another slice illustrating that although morphine reduced the rate of occurrence of SWRs, it did not change network excitability or PPI. (C) Examples of input/output curve (a) and recordings of evoked (upper traces) and simultaneous spontaneous SWRs (bottom traces) (b) showing that morphine at the concentration of 1 mM enhanced excitability, as demonstrated by the drug-induced shift to the left in the curve, but it did not affect recurrent inhibition because it did not change the relationship between PS1 and PS2. The asterisk indicates the appearance of a secondary PS. Note the concomitant strong drug effect on the spontaneous activity. Data were obtained from three different slices. Stimulation artefacts in (b) were truncated. (D) Examples of the effects of 10 mM morphine. Morphine reversibly enhanced network excitability (b) and reduced PPI (a) and (c). In (a), note that because of the short inter-pulse interval in this experiment (8 ms) the secondary PS was masked by the second stimulus artefact. The reduction in inhibition is also shown in the plot made between the PS2/PS1 ratio and the stimulation strength shown in (d). PS2/PS1 ratio was increased with 10 mM morphine at most stimulation strengths. Example of evoked maximal PSs from another slice (e) shows the generation of a secondary PS with 10 mM of morphine. Note that the secondary spikes were abolished by naloxone.
opioid receptors elicit similar cellular events (Pan, 1998) , the differences of the drug potencies observed here could be interpreted as differences in the affinity/efficacy of the drugs for the various opioid receptors (Zernig et al., 1995; Crooks et al., 2006) , as well as different expression of the receptors from physiologically different cell types (Pan, 1998 ). DAMGO's higher potency to suppress inhibition, compared with morphine, could be accounted for by its higher affinity and efficacy for MORs (Chaturvedi et al., 2000; Crooks et al., 2006) and possibly for the various MOR subtypes (Pasternak, 2001 ).
Discussion
Our study demonstrates that the MORs play an important modulatory role on SWRs. All three MOR agonists used displayed prominent, concentration-dependent effects on
Figure 8
DAMGO reduces the strength of recurrent inhibition at a lower concentration than that enhancing network excitability. (A) Examples of the effects of 10 nM DAMGO on the neuronal excitability (a) and PPI (b) are shown. A plot of the PS2/PS1 ratio against the stimulation strength, before and during 10 nM DAMGO, is shown in (c) and examples of recording of PSs evoked by the paired-pulse stimulation (upper traces) and of the simultaneously recorded spontaneous SWRs (lower traces) are shown in (d). (B) The effects of 100 nM DAMGO on the neuronal excitability and PPI are shown in (a) and (b) respectively. Input/output curves between PS amplitude and the stimulus strength show that DAMGO reversibly eliminated the suppressive effect of recurrent inhibition at 100 nM; this effect was reversed by naloxone. The plot in (c) illustrates the significant and reversible effect of 100 nM DAMGO on the PS2/PS1 ratio at a wide range of stimulus intensity. The example in (d) illustrates that 100 nM DAMGO reversibly reduced PPI (upper traces) while at the same time increased the amplitude and reduced the rate of occurrence of spontaneous activity (lower traces). (C) Effects of 1 mM DAMGO. Example of PS/EPSP curves that illustrate the strong leftward shift in the curve induced by 1 mM DAMGO is presented in (a). The example in (b) shows the generation of a large secondary PS under 1 mM DAMGO and its complete block by naloxone (Nalox). The plot on the right shows the collective results of the effect of naloxone (data collected from 5 slices/3 animals). In the example shown in (c), secondary spikes were partly blocked by the antagonist of NMDA receptor CPP, while the remaining component of secondary spikes was blocked by naloxone. The collective results of the consecutive effects of CPP and naloxone on secondary spikes are presented in the right plot (data from 4 slices/2 animals). *P < 0.05, significant effects of CPP or naloxone. Stimulation artefacts in (c) were truncated. ᭣
Figure 9
Collective results of the effects of morphine and DAMGO on the indexes of network excitability (I50, EPSP50, PS/EPSP, second spikes) and paired-pulse inhibition (Shift-I50, PS2/PS1). The numbers in the I50 plot indicate the number of slices/animals used for each drug concentration. *P < 0.05, **P < 0.01, ***P < 0.005. Note that compared with morphine, DAMGO affected the indexes of inhibition at much lower concentrations.
SWRs. The effects were observed even at very low drug concentrations (1-10 nM). Moreover, MOR agonists affected the various characteristics of SWRs differently. All three agonists significantly enhanced the amplitude of sharp waves and increased the probability of occurrence of sequences of SWRs. They also reduced the mean rate of episodes of SWRs (i.e. they dampened the likelihood of initiation of new episodes). Ripple oscillation was suppressed by relatively high concentrations (Ն100 nM) of opioid agonists; however, low concentrations of morphine (5-10 nM) significantly enhanced ripples. Morphine and DAMGO altered network excitability and recurrent inhibition, displaying different potencies. These effects were reversed by antagonists of MORs.
Interpretation of drug effects -implications for the mechanisms underlying SWRs
The similar effects of MOR agonists on the amplitude of sharp waves, the initiation of episodes and the incidence of sequences suggested a common mechanism of action. Because changes were observed at concentrations as low as those of endogenous m-opioids in the rat brain (Lam et al., 2008) , these changes might reflect the modulation of SWRs by endogenous opioids. In the hippocampus, MORs are almost exclusively located on GABAergic inhibitory interneurons (Drake and Milner, 2002) and opioid agonists modulate inhibition (Nicoll et al., 1980; Lupica, 1995) and increase the excitability of the pyramidal cells (Zieglgansberger et al., 1979; Masukawa and Prince, 1982; Swearengen and Chavkin, 1987) . In CA1, opioids suppress synaptic inhibition by hyperpolarizing GABAergic interneurons especially those that project to the perisomatic domain of principal neurons (Madison and Nicoll, 1988; McQuiston, 2008) . In keeping with these observations, we found that MOR agonists enhanced network excitability and decreased inhibition. However, as those effects on SWRs produced by low opioid concentrations (<100 nM) were observed in the absence of change on the overall neuronal network excitability and inhibition, we would propose that the modulation of SWRs requires relatively small and specific alterations in the GABAergic transmission which cannot be easily detected by stimulation that engages a rather large part of the local network. The different potencies observed between the three MOR agonists might result from the different affinities/ efficacies of the three compounds for the MORs (Zernig et al., 1995; Crooks et al., 2006) .
The reduction in the occurrence of SWR episodes is consistent with the suppressive effect of MOR agonists on the activity of GABAergic interneurons, and recent findings suggest that the initiation of episodes of SWRs is favoured by slight enhancement of GABA A receptor-mediated transmission (Ellender et al., 2010; Koniaris et al., 2011) .
The generation of the ripple oscillation requires an accurate balance between excitation and inhibition in the local network. Interestingly, in the present study MOR agonists suppressed ripple oscillation at the same concentration (100 nM) that they disturbed the excitation/inhibition balance. This suppressive effect is consistent with the selective localization of MORs on PV cells (Drake and Milner, 2002) and the critical role these cells play in the generation of ripples (Klausberger et al., 2004) . In addition to the strong activation of PV cells, recent observations suggest that ripples also require a rather mild increase in principal cell excitation (Racz et al., 2009; Koniaris et al., 2011; Maier et al., 2011) . This may be related to our finding that low concentrations of morphine enhanced ripples. We found that DAMGO suppressed inhibition more readily than it increased excitability. Morphine displayed a much lower potency in reducing inhibition than in enhancing excitability. That is, at relatively low concentrations morphine (but not DAMGO) changed network excitability inducing a shift of the excitation/ inhibition balance towards excitation. Although the effect of 5 nM morphine on the evoked responses was not statistically significant, it is plausible that small changes in the excitation/inhibition balance may also occur in the nanomolar range leading to moderate increase of the excitation in the local network and consequently to augmentation of ripples.
The enhancement of clusters by MOR agonists is consistent with their effect on excitation/inhibition balance and agrees with previous observations showing that even small enhancements in GABA A receptor-mediated transmission suppress clusters . The generation of sequences requires activation of NMDA receptors (Papatheodoropoulos, 2010) whose activity can be uncovered by MORs (Swearengen and Chavkin, 1987; McQuiston, 2008) . In the present study, DAMGO produced a marked increase in the probability of cluster occurrence at the same concentration (1 mM) that elicited NMDA-dependent secondary spikes. Thus, network disinhibition and NMDA receptor activation resulting from the increased activation of MORs is a condition that favours the generation of clusters.
We found that all three MOR agonists increased the amplitude of sharp waves. In the CA1 area, sharp waves correspond to GABAA receptor-mediated IPSPs (Papatheodoropoulos and Kostopoulos, 2002; Wu et al., 2002; Maier et al., 2003) and their amplitude is correlated with the amplitude of IPSPs on pyramidal neurons (Papatheodoropoulos, 2010) . In view of the suppressive effect of MOR agonists on IPSPs (Nicoll et al., 1980; Masukawa and Prince, 1982; Capogna et al., 1993; McQuiston, 2008) , these agonists should suppress rather than increase the amplitude of sharp waves in CA1. However, although MOR agonists act mainly on PV cells (Drake and Milner, 2002) , the latter are not the only contributors to the generation of SWRs. Bistratified cells are also involved in SWRs (Klausberger et al., 2004) . Additionally, SWRs in CA1 are triggered by excitatory input from CA3 (Csicsvari et al., 2000) and sharp waves in CA3 pyramidal cells correspond to excitatory rather than inhibitory synaptic activity (Wu et al., 2002; Colgin et al., 2004; Behrens et al., 2005) . Thus, disinhibition of CA3 pyramidal cells by MOR agonists could lead to higher excitation of their targets in CA1 including pyramidal cells (Dingledine, 1981; McQuiston, 2008) and inhibitory bistratified cells (Freund and Buzsaki, 1996) . Consequently, the enhancing effect of MOR agonists on the amplitude of sharp waves in CA1 could also be explained by a higher activity of bistratified inhibitory cells in this field, following their higher activation from disinhibited CA3 principal cells.
Recent findings show that MORs readily control the activity of ivy and neurogliaform GABAergic cells in the CA1 area (Krook-Magnuson et al., 2011) . However, their contribution to the modulation of SWRs is uncertain because ivy and neurogliaform cells do not change their firing activity during SWRs (Fuentealba et al., 2008a) .
Implications for the drug effects on memory
The effects of opioids on learning and memory appear diverse because of the variety of opioid receptors (Pan, 1998; Jamot et al., 2003) , the learning task and animal species used (Morris and Johnston, 1995) , as well as the interaction of opioids with other neurotransmitter/neuromodulator systems (McGaugh, 2002; Hadjiconstantinou and Neff, 2011) . A consistent pattern of effects is disclosed when the time of drug administration is taken into account; morphine impairs memory when present during encoding (Castellano, 1975) but facilitates memory when administered after the training/ learning sessions (White et al., 1978; Mondadori and Waser, 1979; Staubli and Huston, 1980) . Furthermore, memory is more consistently facilitated by intrahippocampal/ intraventricular (Meilandt et al., 2004; Hunsaker et al., 2007) than peripheral drug injections (Izquierdo, 1979; Veselis et al., 1994) . The facilitatory effect may represent drug effect on the memory consolidation, a process thought to encompass hippocampo-neocortical information transfer through the activity of SWRs (Chrobak and Buzsaki, 1994; Wierzynski et al., 2009) . SWRs might arise from an assembly of hippocampal cells interconnected by synapses that have been strengthened during encoding of new information, and such an assembly may underlie a particular memory trace in the hippocampus (Buzsaki, 1989) . The SWR-associated, offline reactivation of this assembly may then contribute to further strengthening of hippocampal and neocortical synapses, assisting memory consolidation (Buzsaki, 1989) . Recent evidence showing that synaptic strengthening accompanies the emergence (Behrens et al., 2005) and potentiation (Papatheodoropoulos, 2010) of SWRs supports this hypothesis. Similarly, the observed increase in amplitude of sharp waves induced by MOR agonists may contribute to synaptic strengthening inside a sharp wave-associated cell assembly assisting the establishment/maintenance of memory trace. Hence, the facilitatory effect of activating MORs on hippocampus-dependent memory may involve long-term synaptic modification. Indeed, activation of MORs facilitates the induction of long-term potentiation in hippocampal synapses (Martinez et al., 2011) .
The effect of MOR agonists on the sequences of SWRs might have important consequences on memory function as the former appear to reflect specific aspects of information processing by the hippocampal circuit. Recent observations suggest that sequences may represent compressed activity that corresponds to long paths the animal traverses in space, and thus they may be involved in the memorization of prolonged experiences (Davidson et al., 2009) .
It is of note that, although moderate to relatively high concentrations (Ն100 nM) of all the MOR agonists tested reduced ripples, low concentrations of morphine (5-10 nM) produced a considerable increase in the ripple oscillation supporting the idea that endogenous opioid levels may positively modulate memory. An increase in ripple quantity and power has been found after learning, and has been correlated with increased hippocampus-dependent memory performance (Ramadan et al., 2009) . Additionally, reduced performance was observed during pharmacologically induced reduction of the ripple power (Robbe et al., 2006) . Interestingly, low concentrations of the MOR agonists did not alter the total number of SWR events. Stability in the quantity of SWRs has been observed in parallel with long-term increase in the amplitude of sharp waves and frequency of clusters, following q-burst stimulation (Papatheodoropoulos, 2010) . Therefore, the enhancing effects of MOR agonists on SWRs are consistent with the behavioural data that show MORinduced facilitation of memory consolidation, and they suggest that this effect may entail the modulation of opioids on SWRs. Moreover, the fact that MOR-mediated modulation of SWRs apparently involves only subtle changes in the excitation/inhibition balance is consistent with the hypothesized role of SWRs in the processes of transfer and consolidation of discrete memory traces given that these processes have to be selective and accurate employing small neuronal circuits, and thus keeping fidelity (Sutherland and McNaughton, 2000) .
In this study, we have determined the roles played by MOR agonists in the hippocampal activity of SWRs. Morphine, DAMGO and fentanyl significantly modulated the activity enhancing the amplitude and the sequencing of sharp waves and dampening the initiation of distinct episodes. Low-level activation of MORs, not affecting network excitability and recurrent inhibition, produced an augmentation of the ripple oscillation. These results show for the first time that MOR agonists at concentrations comparable to endogenous levels of opioids exerted a dynamic regulation on SWRs, presumably by finely tuning the balance between excitation and inhibition. To some extent, such modulation may underlie the actions of MOR agonists on hippocampusdependent memory.
